Diagnostic Performance and Safety of Pegsitacianine for the Detection of Cancer in Patients With Unknown Primary Head and Neck Cancer

Conditions:   Head and Neck Cancer;   Unknown Primary Cancer;   Head and Neck Squamous Cell Carcinoma Intervention:   Biological: Pegsitacianine Sponsor:   University of Texas Southwestern Medical Center Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials